Literature DB >> 21136879

Myofilament proteins: From cardiac disorders to proteomic changes.

Chao Yuan1, R John Solaro.   

Abstract

Myofilament proteins of the cardiac sarcomere house the molecular machinery responsible for generating tension and pressure. Release of intracellular Ca(2+) triggers myofilament tension generation and shortening, but the response to Ca(2+) is modulated by changes in key regulatory proteins. We review how these proteomic changes are essential to adaptive physiological regulation of cardiac output and become maladaptive in cardiac disorders. We also review the essentials of proteomic techniques used to study myofilament protein changes, including degradation, isoform expression, phosphorylation and oxidation. Selected proteomic studies illustrate the applications of these approaches.
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2008        PMID: 21136879     DOI: 10.1002/prca.200780076

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  12 in total

Review 1.  Top-down mass spectrometry of cardiac myofilament proteins in health and disease.

Authors:  Ying Peng; Serife Ayaz-Guner; Deyang Yu; Ying Ge
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

2.  Nitroxyl, redox switches, cardiac myofilaments, and heart failure: a prequel to novel therapeutics?

Authors:  Ying Ge; Richard L Moss
Journal:  Circ Res       Date:  2012-09-28       Impact factor: 17.367

3.  Top-Down Proteomics Reveals Myofilament Proteoform Heterogeneity among Various Rat Skeletal Muscle Tissues.

Authors:  Jake A Melby; Yutong Jin; Ziqing Lin; Trisha Tucholski; Zhijie Wu; Zachery R Gregorich; Gary M Diffee; Ying Ge
Journal:  J Proteome Res       Date:  2019-11-07       Impact factor: 4.466

Review 4.  Comprehensive analysis of protein modifications by top-down mass spectrometry.

Authors:  Han Zhang; Ying Ge
Journal:  Circ Cardiovasc Genet       Date:  2011-12

5.  Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy.

Authors:  Emily M Schulz; Tanganyika Wilder; Shamim A K Chowdhury; Hajer N Sheikh; Beata M Wolska; R John Solaro; David F Wieczorek
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

6.  Comprehensive assessment of chamber-specific and transmural heterogeneity in myofilament protein phosphorylation by top-down mass spectrometry.

Authors:  Zachery R Gregorich; Ying Peng; Nicole M Lane; Jeremy J Wolff; Sijian Wang; Wei Guo; Huseyin Guner; Justin Doop; Timothy A Hacker; Ying Ge
Journal:  J Mol Cell Cardiol       Date:  2015-08-09       Impact factor: 5.000

7.  Top-down Mass Spectrometry of Sarcomeric Protein Post-translational Modifications from Non-human Primate Skeletal Muscle.

Authors:  Yutong Jin; Gary M Diffee; Ricki J Colman; Rozalyn M Anderson; Ying Ge
Journal:  J Am Soc Mass Spectrom       Date:  2019-03-04       Impact factor: 3.262

8.  Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution.

Authors:  Xiaoke Yin; Friederike Cuello; Ursula Mayr; Zhiqi Hao; Martin Hornshaw; Elisabeth Ehler; Metin Avkiran; Manuel Mayr
Journal:  Mol Cell Proteomics       Date:  2009-12-27       Impact factor: 5.911

9.  Top-down proteomics reveals concerted reductions in myofilament and Z-disc protein phosphorylation after acute myocardial infarction.

Authors:  Ying Peng; Zachery R Gregorich; Santosh G Valeja; Han Zhang; Wenxuan Cai; Yi-Chen Chen; Huseyin Guner; Albert J Chen; Denise J Schwahn; Timothy A Hacker; Xiaowen Liu; Ying Ge
Journal:  Mol Cell Proteomics       Date:  2014-06-26       Impact factor: 5.911

10.  Temperature-sensitive sarcomeric protein post-translational modifications revealed by top-down proteomics.

Authors:  Wenxuan Cai; Zachary L Hite; Beini Lyu; Zhijie Wu; Ziqing Lin; Zachery R Gregorich; Andrew E Messer; Sean J McIlwain; Steve B Marston; Takushi Kohmoto; Ying Ge
Journal:  J Mol Cell Cardiol       Date:  2018-07-23       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.